CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Montreal, Quebec, Canada and 17 other locations
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-3712 in healthy adults and patients with atopic d...
Phase 1
Montreal, Quebec, Canada
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...
Phase 1
Montreal, Quebec, Canada and 13 other locations
the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...
Phase 2
Montréal, Quebec, Canada and 21 other locations
The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis a...
Phase 1
Montréal, Quebec, Canada and 8 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Montreal, Quebec, Canada and 47 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Montreal, Quebec, Canada and 83 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Montreal, Quebec, Canada and 541 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Montreal, Quebec, Canada and 555 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Montreal, Quebec, Canada and 193 other locations
Clinical trials
Research sites
Resources
Legal